Entecavir Inhibits HIV at Reduced Viral Inoculum
The HBV drug entecavir has anti-HIV activity at a low viral inoculum and shouldn’t be used in HIV/HBV-coinfected patients who are not receiving combination ART.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)